E-ISFA 2020 Announcement

3rd Congress of the European Group – International Society for Apheresis (E-ISFA)

Dresden, March 19 to 21, 2020

Congress Topics

  • Recent progress in lipoprotein apheresis
    • Homozygous familial hypercholesterolemia
    • Lipoprotein(a)
    • Competition with drugs
  • Plasma exchange
  • Immunoadsorption – indications, results, future perspectives
  • Experience with extracorporeal therapy in children and during pregnancy
  • Apheresis Registries
  • How to assure the quality of care in extracorporeal therapy
  • Psychosocial aspects in patients undergoing extracorporeal therapy
  • Apheresis in transplantation
  • New developments
    • Specific elimination of C-reactive Protein
      • After myocardial infarction, after other diseases
    • Other new devices
  • Extracorporeal Photopheresis
  • Cellular Therapies
  • Actual aspects of lipid-lowering therapy
    • New data on PCSK9 inhibitors
    • Antisense oligonucleotides against apolipoprotein CIII and apolipoprotein(a)
    • Bempedoic acid – current status
    • New preparations of omega-3 fatty acids
    • Lomitapide
    • Latest study data

Further activities

  • Sessions for medical staff (mostly in German)
    • Role of the medical staff in an Apheresis center
    • Psychological aspects
    • Venous access problems
    • Problems when treating children
    • Different apheresis methods – advantages, disadvantages
    • Other developments
  • Special sessions organized by the industry (experience with apheresis devices, actual recommendations, troubleshooting)
  • Actual topics in lipidology (in German, on Friday, March 20, 2018 in the afternoon, free entrance to all people wishing to attend)

Further information will follow in spring 2019

Lascia un commento

Il tuo indirizzo email non sarà pubblicato.